Targeted Therapies - Fitz Flashcards

1
Q

How do tyrosine kinase inhibitors work?

A

Bind to ATP-binding site on TK and prevent enzyme from using ATP to phosphorylate target proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Imatinib

A

Bcr-Abl tyrosine kinase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dasatinib

A

Bcr-Abl tyrosine kinase inhibitor (Imatinib-resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does CML become resistant to Imatinib?

A

Slight mutation of Bcr-Abl TK ATP binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Imatinib uses

A

CML, GIST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dasatinib

A

CML (Imatinib-resistant), [Ph]+ ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GIST has what TK mutations?

A

C-Kit, PDGFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

EGFR inhibitors

A

Lapatinib, Gefitinib, Erlotinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HER2 receptor inhibitor

A

Lapatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PDGFR/VEGFR inhibitors

A

Sunitinib, Sorafenib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inhibiting RTKs causes inhibition of what?

A

Downstream RAS/PI3K, AKT oncogenic signaling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

EGFR…what cancer?

What drugs?

A

NSCLC

Erlotinib, Gefitinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EGFR + HER2…what cancer?

What drug?

A

Breast

Lapatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

C-KIT…what cancer?

What drugs?

A

GIST

Sunitinib, Imatinib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PDGFR, VEGFR…what cancer?

What drugs?

A

RCC

Sunitinib, Sorafenib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BRAF kinase…what cancer?

What drug?

A

Melanoma

Vemurafinib

17
Q

Anti-EGFR antibody drugs

A

Cetuximab, Panitumumab

18
Q

Anti-HER2 receptor antibody drug

A

Trastuzumab

19
Q

Anti-VEGF ligand antibody drug

A

Bevacizumab

20
Q

Bevacizumab (anti-VEGF) is used in what cancer?

Why is it good in this cancer?

A

RCC

Prevents angiogenesis, since RCC (VHL mutation) causes VEGF overproduction due to HIF accumulation causes highly vascular tumor

21
Q

If a tumor is K-RAS positive, think what?

A

Cannot use an RTK inhibitor drug, must think otherwise

22
Q

Rituximab

A

Anti-CD20 antibody, used for B-cell lymphoma (NHL) and leukemia (CLL)

23
Q

3 “degrees” of Rituximab action on B-cells

A
  • Complement-mediated cell lysis
  • NK/T-cell cell lysis
  • Apoptosis signal
24
Q

When during treatment should antibody drugs be used?

A

Before chemo (sensitize tumor) or after (BM recovery 1st)

25
Q

Aromatase inhibitor drugs

A

Anastrazole, Exemestane

26
Q

When are Aromatase inhibitors beneficial?

Age group?

A

If the breast cancer is producing estrogen

Post-menopause (ovaries can’t override the estrogen block)